R&D Podcasts | pharmaphorum

Podcasts

R&D

pharmaphorum podcast Episode 224, Sigma Mostafa, KBI Biopharma

CDMOs: Their crucial role and how to select one, with Sigma ...

Sigma Mostafa, CSO at KBI BioPharma, discusses the role of CDMOs and the important factors companies should consider when selecting one.

R&D

pharmaphorum podcast Episode 223, Shawn Hodges, Revelation Pharma

On US drug shortages and compounding pharmacies, with Shawn ...

Shawn Hodges, CEO of Revelation Pharma, discusses the true state of drug shortages in the US at the moment and the role of compounding pharmacies.

R&D

pharmaphorum podcast Episode 221, Sandeep Kulkarni, Tourmaline Bio

On inflammation, heart health, and GLP-1 possibilities, with...

Sandeep Kulkarni, CEO of Tourmaline Bio, discusses inflammation, & the impact of AI and GLP-1s on cardiology clinical trials and drug development.

R&D

pharmaphorum podcast Episode 202, Piet van der Graaf, Certara

On digital twins in rare disease research, with Piet van der...

Piet van der Graaf, Senior VP at Certara discusses the potential of digital twins in rare diseases research.

R&D

black lady smiling and looking at laptop

Working together to innovate on pragmatic clinical trials, w...

In today’s episode, host Jonah Comstock speaks with Rob DiCicco, vice president of portfolio management at TransCelerate Biopharma.

R&D

Biotech’s biggest challenge isn’t scientific, but political ...

We speak to James Roosevelt Jr, a longtime healthcare leader, former associate commissioner of social security for retirement policy & grandson of FDR